在与甲相关的死亡中描述死后血度
Guido Pelletti1,2, Valentina Giunchi3, Paolo Fais4,5
1Department of Medical and Surgical Sciences, Unit of Legal Medicine, University of Bologna, Via Irnerio 49, 40126, Bologna, Italy.
International journal of legal medicine
|October 8, 2025
概括
甲的转移正在上升. 这项研究分析了与甲有关的死亡,发现重叠的治疗和毒性血液度,特别是在多种药物使用时. 调查结果有助于法医解释甲毒性.
科学领域:
- 法医毒理学 法医毒理学
- 药理学 药理学是指药理学的学科.
- 公共卫生 公共卫生
背景情况:
- 甲对于阿片类药物成治疗至关重要,但面临着越来越多的全球转移.
- 由于耐受性和多重物质使用,确定甲在死亡中的作用是复杂的.
- 法医解释死后的甲水平需要了解人口和临床因素.
研究的目的:
- 确定甲相关死亡的人口,临床和治疗特征.
- 支持法医病理学家解读死后的甲度.
- 分析血中甲水平与死亡原因之间的关系.
主要方法:
- 与死后毒理学相关的甲相关死亡的系统文献综述.
- 从文献和博洛尼亚法医学研究所的240个个案例中整合审查的数据.
- 对人口统计数据,血液中甲醇度和辅毒剂的分析.
主要成果:
- 血液中甲的中位数度为300 ng/mL (儿童) 和503 ng/mL (成人),与治疗水平重叠.
- 与多种药物中毒 (p < 0.001) 相比,仅因甲导致的死亡中发现了更高的甲血度.
- 治疗性和有毒的甲血度之间存在显著的重叠,强调了多种物质使用的风险.
结论:
- 与甲相关的死亡因重叠的度范围而具有复杂的毒理学特征.
- 该研究强调了与涉及甲的多种药物中毒相关的日益增加的风险.
- 这篇全面的案例审查为法医解读甲毒性提供了宝贵的资源.
相关概念视频
Drug Concentrations: Measurements
1.1K
Drug concentration is the quantity of a drug present in a biological sample. Measuring drug amounts in biological samples allows the clinician to understand how a drug is absorbed, distributed, metabolized, and excreted. Samples can be obtained through invasive or non-invasive methods. Invasive techniques involve surgical or parenteral interventions to gather blood, cerebrospinal fluid, or tissue biopsy. Conversely, non-invasive approaches provide samples like urine, feces, and saliva.
Plasma...
Plasma...
1.1K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
180
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
180
Therapeutic Drug Monitoring: Drug Analysis Methods
177
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
177
Determination of Michaelis Constant and Maximum Elimination Rate
436
The Michaelis constant (KM) and the theoretical maximum process rate (Vmax) are vital parameters in the Michaelis-Menten equation, central to many biochemical reactions. They provide essential insights into enzyme kinetics and drug metabolism.
These parameters can be estimated by analyzing plasma concentration data post-drug administration. A notable example of this application is phenytoin, a drug with capacity-limited kinetics. It's recommended that phenytoin should be administered at two...
These parameters can be estimated by analyzing plasma concentration data post-drug administration. A notable example of this application is phenytoin, a drug with capacity-limited kinetics. It's recommended that phenytoin should be administered at two...
436
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
212
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
212
Therapeutic Drug Monitoring: Affecting Factors
200
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
200


